Understanding forgiveness: minding and mining the gaps between pharmacokinetics and therapeutics
L G Osterberg1, J Urquhart, T F Blaschke
1Department of Medicine, Stanford University School of Medicine, Stanford, California, USA. larso@stanford.edu
Clinical Pharmacology and Therapeutics
|September 22, 2010
Summary
Maintaining consistent drug action in long-term pharmacotherapy requires adherence to prescribed dosing regimens. Interruptions can disrupt drug effectiveness, with outcomes depending on various patient and treatment factors.
Area of Science:
- Pharmacology
- Clinical Pharmacy
- Drug Action
Background:
- Long-term pharmacotherapy aims to sustain drug efficacy.
- Consistent dosing regimens are crucial for therapeutic continuity.
- Dosing interruptions can compromise treatment outcomes.
Purpose of the Study:
- To highlight the importance of dosing continuity in pharmacotherapy.
- To discuss factors influencing the consequences of dosing interruptions.
Main Methods:
- Literature review on pharmacotherapy principles.
- Analysis of factors affecting drug action continuity.
Main Results:
- Continuity of drug action depends on adherence to dosing schedules.
- Consequences of interrupted dosing are variable.
- Factors influencing outcomes include interruption length, drug properties, and patient history.
Conclusions:
- Maintaining uninterrupted pharmacotherapy is essential for sustained drug action.
- Understanding variables affecting dosing interruptions is key for effective patient management.
Related Concept Videos
01:24Pharmacokinetic–Pharmacodynamic Relationship: Problems
The empirical approach to drug therapy optimization relies on correlating pharmacological response with administered dosage. Such an approach can be costly, time-consuming, and often yields poor correlation due to variables like formulation factors and drug elimination characteristics. A more precise approach correlates response with plasma drug concentration or the amount of drug in the body, rather than dosage. This is achieved through pharmacokinetic-pharmacodynamic (PK/PD) modeling, which...
01:01Dosage Regimens: Partial Pharmacokinetic Parameters
It is not uncommon for complete drug pharmacokinetic profiles to remain elusive in pharmacokinetics. This necessitates certain educated assumptions by pharmacokineticists to determine appropriate dosage regimens without comprehensive pharmacokinetic data from animal or human studies. One prevalent assumption is setting the bioavailability factor, denoted as F, to 1 or 100%. This assumption caters to the scenario where a drug doesn't achieve full systemic absorption, resulting in the patient...
01:27Pharmacogenetics of Drug Metabolism: Overview
Genetic polymorphism in drug metabolism is crucial to the inter-individual variability observed in drug responses. Drug metabolism primarily involves the chemical modification of drugs and other xenobiotics to enhance their elimination by increasing their polarity. Two main classes of enzymes mediate this biotransformation process: Phase I enzymes, primarily cytochrome P450s, catalyze oxidation and reduction reactions, while other enzymes, such as esterases, mediate hydrolysis, and Phase II...
01:10Pharmacokinetics: Overview
Pharmacokinetics is a scientific discipline that focuses on the journey of a drug within the body, encompassing four key stages: absorption, distribution, metabolism, and elimination. The first stage, absorption, involves the drug's transfer into the bloodstream. Several factors dictate the extent and speed of this process. For example, the liver often metabolizes oral drugs before they reach systemic circulation, leading to only partial absorption. In contrast, intravenous (IV) administration...
01:19Nonlinear Pharmacokinetics: Overview
Nonlinear or dose-dependent pharmacokinetics is a phenomenon that occurs when the pharmacokinetic parameters of certain drugs deviate from linear pharmacokinetics at higher doses. These drugs do not follow the expected first-order kinetics, where the rate of drug elimination is directly proportional to the drug concentration. Instead, they exhibit a nonlinear relationship, which can be attributed to several factors.
Nonlinearity can arise due to the saturation of plasma protein-binding or...
Nonlinearity can arise due to the saturation of plasma protein-binding or...
01:29Pharmacogenetics and Pharmacogenomics: Overview
Pharmacogenetics and pharmacogenomics examine how genetic factors influence an individual's response to drugs. While pharmacogenetics focuses on the impact of specific genetic variants on drug effects, pharmacogenomics takes a broader approach, studying how genetic variation across populations contributes to differences in drug responses. These fields aim to explain why individuals may experience varying levels of efficacy or adverse reactions to the same medication.Variability in drug...